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INTRODUCTION
Malaria is the most important parasitic human disease which
kills between 1.5 and 2.7 million people in endemic areas [1].
Asexual blood stages of malaria parasites are responsible for all
the morbidity and mortality of the disease [2]. A better under-
standing of the immune responses against these stages will be
an important step towards development of effective vaccines to
reduce clinical disease and prevent death. For this purpose, find-
ings from experimental studies on both single and mixed infec-
tions are useful because in humans mixtures of different species
and different genotypes of the same species of malaria parasites
are common in malaria-endemic regions [3]. 
Acquired immunity to the asexual blood stages of malaria in
mice involves both cell-mediated and antibody-dependent mech-
anisms through activation of 2 subsets of CD4+ T cells, i.e., Th1
and Th2 cells [4]. In a self resolving P. chabaudi AS infection,
there was a sequential Th1/Th2 response in which the Th1 sub-
set responsible to control the acute phase of the patent para-
sitemia while Th2 response rises when infection becomes chron-
ic [5,6] and could play a role in the elimination of the infection
[7]. In a virulent infection of P. yoelii, a failure to induce ade-
quate activation of both Th1 and Th2 subsets resulted in a fatal
outcome [8]. In susceptible A/J mice, spleen cells produce a lower
level of IFN-g and early higher levels of IL-4 and IL-10 compared
to infection in resistant B6 mice in P. chabaudi AS infections
[9,10].   
It is known that IFN-g is central to the induction of IgG2a pro-
duction which indicates a Th1 response while IL-4 indicates pro-
duction of IgG1 and Th2 activation [11]. IFN-g plays an impor-
tant role in resistance to asexual blood stages of malaria via acti-
vated macrophages which kill parasites through phagocytosis
and by release of reactive oxygen molecules which have been
shown to destroy intraerythrocytic P. yoelii in vitro [12]. Moreover,
IFN-g gene knockout (GKO) C57BL/6 mice infected with P.
chabaudi AS had higher morbidity and mortality compared to
controls [13-15]. 
In mice infected with P. chabaudi AS, IgG2a is a predominant
antibody during the acute primary parasitemia followed by a
rise in IgG1 in the chronic phase as a result of CD4+ Th1 to Th2
switching [16,17]. Smith and Taylor-Robinson [6] compared
the humoral response in inbred NIH mice infected with pairs
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of parasites from virulent and avirulent strains; lethal P. chabau-
di 7/F1 with non-lethal P. chabaudi AS, and lethal P. yoelii 17XL
with non-lethal P. yoelii 17XNL strains. Their results showed that
in non-lethal infections there was an early significant up-regu-
lation of IgG2a followed by later IgG1 production while in lethal
infections the IgG2a levels were slower and reduced which would
result in a rapid fatal outcome before IgG1 levels significantly
synthesized [6]. 
Inducing both Th1 and Th2 responses through immunization
is an important aim for malaria control because both humoral
and cellular responses are required for resolution of infection
[18,19]. Both IFN-g and IL-4 responses are produced when
BALB/c mice were immunized with a genomic P. chabaudi adami
DS expression library constructs and challenged with P. chabau-
di adami DS [20] as a stringer model for evaluation of vaccine
efficacy [21,22]. 
Mixed malaria infection studies in both humans and rodents
provide information on the kinetics of the course of infection,
the impact on clinical outcome [23], and the immune respons-
es induced compared with that in single strain species infections.
The course and pathological effects of a single infection may be
altered by the presence of another species [24,25]. Epidemiological
studies suggested that a Plasmodium vivax infection might ame-
liorate a subsequent infection with Plasmodium falciparum [26].
Cross-species immunity in murine malaria parasites [27,28] and
the specificity of clearance mechanisms of the acute primary
parasitemia have also been shown [29,30]. Studies of the dynam-
ics of mixed infection using a DNA hybridization assay showed
that when CBA/Ca mice were simultaneously inoculated with
a mixture of cloned lines of P. chabaudi chabaudi and P. yoelii no
deaths were observed compared to the control groups infected
with a single line of each parasite in which low but consistent
mortality was observed [25]. These results show that the outcome
of mixed infections is influenced by the composition of the infect-
ing parasite populations. In mixed infections when a species or
genotype-specific response cleared the majority population [31],
the minority populations could later expand [32]. 
The present study determined and compared the immune
responses, cross-immunity, and inter-reaction between 2 malar-
ia parasite strains, the DK and the DS strains of P. chabaudi adami
which differ in virulence, in a resistant rodent host, the female
NIH mouse in both single and mixed infections. The influence
of virulence and the effect of a low infective dose of the DS strain
on the course of single or mixed infections were also studied.
MATERIALS AND METHODS
Mice
Female NIH mice (Harlan Laboratories, Bicester, UK) were
kept in the Joint Animal Facility, Glasgow University, and used
when they were at about 6-8 weeks of age. If it was required,
mice were kept in a reverse light/dark cycle, with light from 19 : 00
to 07 : 00. They were fed with standard diet (Beekay Universal
Ltd, Alborough, UK) before infection and on diet CRM (S. & S.
Scotland Ltd, UK) after infection. 
Parasites
Avirulent, P. chabaudi adami DK, and virulent P. chabaudi
adami DS strains (courtesy of the late Professor David Walliker,
University of Edinburgh, UK) were used. The capsule of the cry-
opreserved infected blood was taken from liquid N2 and thawed
in a 37℃ water bath (Gallencamp, Daresbury, UK) or in the
hand. To the thawed blood, an equal volume of 0.3 ml 17%
sorbitol, was mixed and then inoculated intraperitoneally (i.p.)
into a mouse. Parasites were then maintained if required by sub-
passage through susceptible mice. Briefly, infected mice were
sacrificed in a CO2 chamber and bled by cardiac puncture and
into a syringe containing sodium heparin at 10 i.u. heparin per
ml of blood. The parasitemia of the donor mouse was deter-
mined by examination of a Giemsa (Gurr BDH Ltd, Dorset, UK)
stained thin blood smear. The infected blood was subsequently
diluted to give the required infective doses of the parasitized red
blood cells (pRBCs). Here, infective doses were 1 × 104 pRBCs
for P. chabaudi adami DS, 1 × 105 pRBCs for P. chabaudi adami
DK, and a mixture of 2 × 103 pRBCs of DS plus  8 × 103 pRBCs
of DK (1 × 104 total) for mixed infection in 0.25 ml PBS which
were inoculated intravenously (i.v.). Non-infected red blood
cells were added to the diluent of PBS to avoid spontaneous
lysis of pRBCs at a very low concentration of RBCs. 
Chloroquine treatment
Sub-curative dose of chloroquine (chloroquine disulphate salt,
Sigma, St. Louis, Missouri, USA), 24 mg/kg was given i.p. to the
mice infected with virulent DS parasites.
Determination of parasitemia
Parasitemia was determined by examination of Giemsa stained
thin blood smears collected daily from sample mice and viewed
under oil immersion (Gurr BDH). 
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Presentation of parasitemia
On each day, the parasitemia was determined for each group
as both the mean percentage (at least RBCs of 50 fields at each
microscopy were counted) and the geometric mean (mean log10
pRBCs per 105 RBCs).
Collection of serum
Mice were bled by cardiac puncture and blood was allowed
to clot at room temperature (RT) and was then put into the cold
room for at least 1 hr to give better clot contraction. Contamin-
ating RBCs was separated by centrifugation for 5 min at 6,000 g.
Normally the sample was then aliquoted into 20 ml volumes in
small Eppendorf tubes (Greiner, Stonehouse, UK), labelled,
and stored at -20℃ until required. For small serum samples,
blood was collected (up to 100 ml) from the tail.
Spleen cell culture for proliferation and cytokine assays 
Spleen cells were cultured as described by Daneshvar et al. [33].
The aseptically removed spleen was teased gently in a Petri dish
(Greiner) in RPMI-1640 and splenocytes were harvested with a
sterile Pasteur pipette. All separated spleen cell suspensions were
centrifuged, 10 min at 1,200 g at 4℃, resuspended in 0.3 ml of
Boyle’s solution to lyse erythrocytes. After 3 washes with RPMI
or PBS, the pellets were resuspended in 10 ml of complete RPMI-
1640. The number of viable splenocytes was calculated by dilut-
ing 10 ml of washed spleen cells in 190 ml of 0.2% trypan blue
(Sigma) in PBS using a Neubauer Haematocytometer under
phase contrast microscope (Diavert Leitz, Berlin, Germany).
The cell concentrations were adjusted to 5 × 106 cells/ml per
each well with the final volume of 200 ml and transferred into
triplicate wells of sterile 96-well flat-bottomed tissue culture
plates (IWAKI, Tokyo, Japan). The whole prepared spleen cell
suspensions from infected or naïve mice were separately cul-
tured with pRBCs as antigens, RBCs, medium, or concanavalin
A (Con A, Sigma) as controls. For the pRBCs and the RBCs the
total RBCs was the same. Con A was added at 0.5 mg/well. The
plates were then incubated for 72 hr in 5% CO2 in air in a 37℃
incubator (Flow laboratory, Thame, UK). The supernatants from
each well were then collected and stored at -20℃ until required. 
For the splenocytes proliferation assay, a separate plate was
prepared as above, but it was first incubated for 60 hr and 0.5
mCi (37KBq) [3H] thymidine (Amersham, Little Chalfront, UK)
was then added to each well, and the plate was incubated for a
further 12-18 hr. The cells were harvested on a printed filtermat
(WALLC, Finland) by a harvester machine (Tomtec, Hamden,
Connecticut, USA). Uptake of [3H] thymidine was measured
using liquid scintillation (Opstiscint Hisafe, Wallac, England)
by a b-counter and presented as counts per minute (c.p.m).
Whole spleen cell suspensions from infected or naïve mice
were separately cultured in medium of RPMI-1640 (Gibco Life
Technologies, Paisley, UK) supplemented with 10% fetal calf
serum (FCS) as complete medium, (Labtech International, Ring-
mer, UK) with pRBCs, RBCs, medium, or Con A (Sigma). Con A
was added at 5 mg/ml (final concentration was 0.5 mg/well) as a
positive control and complete RPMI-1640 medium was used as
negative control. 
Preparation of pRBCs and RBCs lysates
Mice were kept in reverse light so that the asexual erythrocyt-
ic cycle was reversed and could be collected in the late morning
when the parasites were mostly at the late ring/trophozoite stage.
P. chabaudi adami DS and DK strain antigens were prepared as
crude antigens from whole blood cells enriched for mature
trophozoite/schizont pRBCs, using the method described by
McDonald & Sherman [34]. Briefly, infected heparinized (10 i.u./
ml) blood was cultured in vitro from ring to trophozoite/sch-
izont stage using the candle jar method of Trager and Jensen [35].
The parasites were then harvested, washed in 5% FCS RPMI-1640
medium (200 g for 10 min), resuspended to their original vol-
ume and run through Whatman CF11 columns to remove leuko-
cytes. The filtrate was washed with PBS and was restored in PBS
to blood volume and then freeze-thawed 5 times by snap freez-
ing the blood cells in liquid N2 and then immediately defrost-
ing in a waterbath at 37℃ to fracture the RBCs and release of
the parasites’ components. The freeze-thawed preparation was
centrifuged at 1,500 g for 10 min, and the supernatant, which is
called lysate, was stored in 50 ml aliquots at - 20℃ until required.
Lysates from non-infected red blood cells as a control and from
mixed infection were similarly prepared. Protein concentration
of lysates was measured using Coomassie Protein Assay reagent
(Pierce, Rockford, Illinois, USA) 
Cytokine analysis by ELISA
Purified anti-mouse cytokines, i.e., IFN-g, IL-4 (PharMingen,
San Diego, California, USA) monoclonal antibodies, were dilut-
ed in 0.1 M NaHCO3 pH 8.2 as a coating buffer at 2 mg/ml.
For each sample, triplicate wells were used. The antibody solu-
tion was added in 50 ml to each well in a 96-well plate, covered,
and incubated overnight at 4℃ in the cold room. The plates
were subsequently washed 3 times with 0.05% Tween in PBS
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pH 7.2, and then blocked with 10% FCS PBS at 200 ml per each
well, covered, and incubated for 1 hr at 37℃. After blocking, the
plate was washed 2 times with 0.05% Tween/PBS. Serial dilu-
tions of recombinant cytokine standards (for IFN-g stock was at
1 mg/ml, and for IL-4 stock was at 0.5 mg/ml, PharMingen) and
the culture supernatants were added to the wells at 50 ml/well,
covered, and incubated at 37℃ for 3 hr. After incubation, the
plate was washed 4 times with 0.05% Tween/PBS, and 50 ml/well
of biotinylated rat anti-mouse cytokine (IFN-g and IL-4, at 2
mg/ml, PharMingen) in 10% FCS PBS were added, covered, and
incubated at 37℃ for 1 hr. After washing 6 times, diluted strep-
tavadin-peroxidase, 100 ml/well in 10% FCS PBS, were added.
The plate was covered, and incubated for 1 hr at 37℃. The plate
was then washed 8 times with 0.05% Tween/PBS, and 100 ml/
well of 3,3′,5,5′-tetramethylbenzidine (TMB MicrowellTM, KPL,
Gaithersburg, Maryland, USA) substrate was added and the
colour allowed to develop. The plate was read at 630 nm with
reference filter at 405 nm using Biolinx Dynatech software (Dy-
natech Laboratoies, Roseville, Canada).
Determination of specific antimalarial IgG (whole, IgG1,
and IgG2a)
The same procedure was used for IgGs detection. However,
lysates of pRBCs and RBCs (control) were diluted to 20 mg/ml
and used as antigen. Total anti-mouse IgG (whole molecule) was
diluted at 1 : 100,000. For IgG1 or IgG2a, biotinylated and the
secondary antibodies were diluted to 2 mg/ml in 10% FCS. 
Statistical analysis
The results presented here are expressed as standard error of
mean (± SEM) for each set of values in each experiment. How-
ever, SEM cannot be shown when it is too small. When com-
parison between 2 variables at the same time point is consid-
ered, Student’s t-tests were performed. When data were compared
between more than 2 groups, two-way or one-way ANOVA,
and their post tests, were performed. A significant result was
considered when the P-value was < 0.05. 
RESULTS
Parasitemia 
In P. chabaudi adami DK-infected mice, the parasitemia peaked
at 23.9% on day 10 post-infection (PI) and then quickly decre-
ased to sub-patent levels on day 15 PI. A recrudescent parasitemia
was seen between days 38 and 43 PI. In the DS infected mice
treated with subcurative dose of chloroquine on day 8 PI, the
peak parasitemia was observed on day 8 PI with a maximum
of 46.1% and declined to sub-patent levels on day 15 PI. A re-
crudescence was detected between days 18 and 24 PI. 
In untreated mice infected with the DS, the parasitemia peaked
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Fig. 1. The course of malaria infections in NIH mice. ( ) Infective dose: 1 ×105 pRBCs of P. chabaudi adami DK; ( ) Infective dose: 1
× 104 pRBCs of P. chabaudi DS and mice treated with chloroquine on day 8 PI; ( ) Infective dose: 1 ×104 pRBCs of P. chabaudi DS in
mice left untreated; ( ) Mixed infection: a mixture of 8 ×103 pRBCs of P. chabaudi adami DK, and 2 ×103 pRBCs of P. chabaudi DS;
( ) Infective dose: 2 ×103 pRBCs of P. chabaudi DS for low dose infection. Sample size was 21 mice for the single infections, 18 mice
for the mixed infection and 6 for the low dose infection. Each data point is a mean % parasitemia. For each time point, ± SEM has been
calculated. However, SEM cannot be shown when it is too small. The peak parasitemia was 23.9% on day 10 PI for DK-infected mice. The
DS-infected mice were treated with a subcurative dose of chloroquine at 24 mg/kg on day 8 PI. 
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at 68.7% on day 10 PI which was significantly higher than that
in the treated group (t-test; P < 0.005). In surviving mice, a re-
crudescent parasitemia was observed between days 21 and 25 PI
(Fig. 1). No deaths were observed in avirulent DK infection and
in the virulent DS infection when mice were choloroquine treat-
ed. However, in untreated DS-infected mice, 60% of mice died.
In the low infective dose DS-infection group, infected with 2
× 103 pRBCs, the peak parasitemia was 54.5% on day 10 PI
which was significantly (t-test; P< 0.005) lower than that in mice
infected with a higher infective dose. In addition, the lower infec-
tive dose extended the prepatent period by 1 day (Fig. 1). The
surviving rate was 33% compared with the 40% in higher infec-
tive dose infections.
The parasitemia in the mixed infection peaked at 40.3% on
day 10 PI (Fig. 1). A recrudescence was observed between days
20 and day 26 PI. The survival rate was 100%. There was a sig-
nificantly lower (t-test; P < 0.0001) parasitemia in the mixed
infections compared to the single infections of P. chabaudi adami
DS, when mice were left untreated. Despite a relatively small
proportion of the virulent DS parasites in the mixed infective
dose, the parasitemia peaked significantly (t-test; P < 0.0001)
higher than that in the single-infections with avirulent DK strain.
Although the number of pRBCs of P. chabaudi adami DS inocu-
lated in the mixed infections and in the single infections with a
low infective dose was the same (2 × 103), the peak parasitemia
in mice infected with a single low infective dose was significant-
ly higher (t-test; P < 0.0045) than that in the mixed infections
(data not shown). 
Splenocyte proliferative responses
In both the single and mixed infections, the evaluation of
proliferative responses showed that the spleen cells from naïve
mice which were exposed to Con A had the highest (Tukey’s test;
P < 0.0001 for the DK, P < 0.0002 for the DS strain) levels com-
pared to all other groups for all time points during the experi-
ments. Over all for all time points, the second highest respons-
es were observed in splenocytes from infected mice exposed to
Con A and the third highest levels of responses were seen for
splenocytes from infected mice, which were re-stimulated with
pRBCs (data not shown).
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Fig. 2. IFN-g production in NIH mice infected with different strains of P. chabaudi adami DK and DS. (A) Mice infected with 1 ×105 pRBCs
of DK strain; (B) Mice infected with 1 ×104 pRBCs of DS and treated with chloroquine; (C) Mice infected with 1 ×104 pRBCs of DS and
left untreated; (D) Mice infected with a mixture of 8 ×103 pRBCs of P. chabaudi adami DK, and 2 ×103 pRBCs of P. chabaudi DS. Super-
natant of splenocytes cultures for each mouse was assayed separately by ELISA. Each data point is the mean ± SEM for an experiment
performed in triplicate. However, SEM is not shown when it is too small. ( ) Splenocytes from infected mice exposed to parasitized RBCs
(pRBCs); ( ) Splenocytes from naive mice exposed to pRBCs; ( ) Splenocytes from infected mice exposed to nRBCs; ( )
Splenocytes from naive mice exposed to nRBCs.
Stimulation index (SI) 
In general, the lower SIs were observed after resolution of the
peak parasitemia and they rose again after the recrudescent par-
asitemia compare to other time points. However, at the peak
parasitemia, the proliferative responses were low compared to
other time points. Splenocytes from mice, infected with the vir-
ulent DS and chloroquine treated, showed the lowest SIs com-
pared to the other groups. 
IFN-g production
Supernatants of splenocyte cultures were used to measure the
cytokines, IFN-g and IL-4. As shown in Fig. 2, in the avirulent
DK strain infection, there was an early production of IFN-g with
the highest level on the first sampling day, day 4 PI, and it
remained at high levels until the peak parasitemia occurred.
On day 11 PI, a day after the peak parasitemia, IFN-g declined
sharply but gradually increased thereafter, particularly after the
recrudescence. The levels of IFN-g in splenocyte cultures of infect-
ed mice were significantly higher (Tukey’s test; P < 0.0001) com-
pared to levels in naïve control mice on the first sampling day.
In virulent DS infections, the same profile was seen. The high-
est levels of IFN-g were seen on the first sampling day, day 3 and
4 PI in treated and untreated mice, respectively, and the lowest
levels were coincident with the peak parasitemia (Fig. 2). The
profile of early production of IFN-g in the mixed infection was
the same as in the single-infections. However, the IFN-g level on
the first sampling day was significantly lower (Tukey’s test; P <
0.001) than that in mice infected with the DK strain and in the
mice infected with virulent DS infection (Tukey’s test; P < 0.0001)
(Fig. 2). 
IL-4 production
In both single and mixed infections, IL-4 levels in supernatants
of splenocyte cultures increased later during the observation
period (Fig. 3). In the early period of observation, in both viru-
lent and avirulent single infections, IL-4 did not increase above
background control levels. The highest levels of IL-4 were detect-
ed on the last sampling days in both the DK and DS infections
which were significantly higher (Tukey’s test; P < 0.001 for the
DK infection, P < 0.0001 for the untreated and treated DS infec-
tions, and P < 0.0001 for mixed infection) compared to the IL-
4 levels of controls for all other time points (Fig. 3). The level
of IL-4 in the mixed infection was significantly lower than that
in the single infections of DS strain in either untreated (Tukey’s
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Fig. 3. IL-4 production in NIH mice infected different strains of P. chabaudi adami DK and DS. (A) Mice infected with 1 ×105 pRBCs of
DK strain; (B) Mice infected with 1 ×104 pRBCs of DS and treated with chloroquine; (C) Mice infected with 1 ×104 pRBCs of DS and left
untreated; (D) Mice infected with a mixture of 8 ×103 pRBCs of P. chabaudi adami DK, and 2 ×103 pRBCs of P. chabaudi DS. Supernatant
of splenocyte cultures for each mouse was assayed separately by ELISA. Each data point is the mean ± SEM for an experiment per-
formed in triplicate. However, SEM is not shown when it is too small. ( ) Splenocytes from infected mice exposed to parasitized RBCs
(pRBCs); ( ) Splenocytes from naive mice exposed to pRBCs; ( ) Splenocytes from infected mice exposed to nRBCs; ( ) Splenocytes
from naive mice exposed to nRBCs.
test; P < 0.001) or treated mice (Tukey’s test; P < 0.001). 
Production of specific antimalarial IgG (total), IgG1, and
IgG2a 
The same profile for IgG (whole molecule; total), IgG1, and
IgG2a antibody production was generally seen in the DK, DS,
and mixed infections. IgG antibody (whole molecule) increased
at or immediately after the peak parasitemia, declined thereafter,
and then increased after the recrudescence, usually with the high-
est levels on the last sampling days (data not shown).
In both single and mixed infections, specific IgG1 did not in-
crease significantly during the acute phase, but increased after
the recrudescence and subsequently remained at high levels dur-
ing the observation period (Fig. 4). The levels of IgG1 on the
last sampling days were significantly (Tukey’s test; P < 0.05 for
all groups) higher compared with the control groups. In mice
infected with a lower DS infective dose the production of IgG1
was not as high as that seen in other experimental groups of DS-
infected mice such as those infected with a higher infective dose.
In general, specific-IgG2a sharply increased at or immediately
after the peak parasitemia, declined thereafter, and rose again
during the later stages of the observation period in all groups.
There were higher levels of IgG2a production in mice surviving
in the untreated DS-infected group compared to the DK-infected
mice or treated DS-infected mice for all time points from day 7
PI onward. There were significantly (Tukey’s test; P < 0.0001)
higher levels of IgG2a in the mixed infection compared to the
DK strain infection and in treated mice infected with the DS strain
(Tukey’s test; P < 0.0004) (Fig. 5). 
DISCUSSION
In the present study, investigation and comparison of the profile
of immune responses in NIH mice single or mixed-infected with
avirulent DK and virulent DS strains was the main aim. Therefore,
the course of infection, production and kinetics of selected
cytokines, and parasite-specific antibodies were examined. 
In the DK and DS single and mixed infections, including mice
infected with a lower infective dose of DS pRBCs, peak parasitemia
was close to the same day post-infection, and this is despite the
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Fig. 4. Specific anti-parasite IgG1 in NIH mice infected with different strains of P. chabaudi adami DK and DS. (A) Mice infected with 1 ×
105 pRBCs of DK strain; (B) Mice infected with 1 ×104 pRBCs of DS and treated with chloroquine; (C) Mice infected with 1 ×104 pRBCs
of DS and left untreated; (D) Mice infected with a mixture of 8 ×103 pRBCs of P. chabaudi adami DK, and 2 ×103 pRBCs of P. chabaudi
adami DS. Sera were collected at different time points for ELISA tests. Each data point is the mean ± SEM for an experiment performed
in triplicate. However, SEM is not shown when it is too small. ( ) Sera from infected mice with DK or DS strains and reacted with the lysate
of pRBCs of P. chabaudi adami DK or DS; ( ) Sera from DK- or DS-infected mice reacted with the lysate of RBCs of naïve mice; ( ) Sera
from naïve mice reacted with the lysate of pRBCs of DK or DS strains; ( ) Sera from naïve mice reacted to the lysate of RBCs from naïve
control mice.
fact that, in the virulent DS-infected mice, the infective dose was
10-fold lower than that in the avirulent DK infection. In mice
infected with the DS strain, a range of mortality between 96.7%
and 36% has been reported [22]. Our results showed 60% mor-
tality in untreated mice infected with 1 × 104 pRBCs, and 34%
when the mice were infected with a lower infective dose of 2 ×
103 pRBCs, and no deaths were recorded in the mixed infections.
A reduced infective dose of 2 × 103 pRBCs of DS, resulted in 1-
day delay in the appearance of a patent parasitemia and a 3-day
delay in the time taken to death compared to infection with the
higher infective dose. This suggests that, in the virulent DS infec-
tion, the parasite density increases more rapidly due to a higher
replication rate compared with the avirulent DK strain infection.
In the mixed infection, the peak parasitemia was significantly
higher than that in the DK strain infection but significantly lower
than that in the untreated mice infected with the DS strain. This
suggests that the presence of the avirulent DK strain may partially
moderate the virulence of the DS infection. Similarly, Snounou
et al. [25] showed that in the presence of P. chabaudi chabaudi CB
the parasitemia of P. chabaudi chabaudi AS and P. chabaudi adami
DS was reduced. Cox and Voller [27] also indicated cross-immu-
nity reactions between rodent species of Plasmodium. 
A relatively large infective dose results in developing more qu-
ickly symptoms in mice [36] and in humans [37]. Thus, Timms
and colleagues [38] reported that C57BL/6J mice infected with
the virulent P. chabaudi chabaudi BC died about a day earlier for
every 10-fold increase in the infective dose. The size of the infec-
tive dose also affects Th1 and Th2 sequential activation. Taylor-
Robinson and Phillips [39] showed that increasing the infective
dose of P. chabaudi chabaudi AS in susceptible A/J mice results
in elevated Th2 responses that lead to a fulminant parasitemia
whereas increasing the infective dose in resistant NIH mice en-
hances IFN-g and reduces IL-4 production promoting a Th1 re-
sponse. Our observations also support the idea that dose affects
disease severity because the survival rates were higher in low dose
DS-infected mice compared with high dose DS-infection. The
amelioration in the severity of disease in low dose infected mice
could be due to giving mice more time to mobilize the immune
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Fig. 5. Specific anti-parasite IgG2a in NIH mice infected with P. chabaudi adami DK and DS strains. (A) Mice infected with 1 ×105 pRBCs
of DK strain; (B) Mice infected with 1 ×104 pRBCs of DS and treated with chloroquine; (C) Mice infected with 1 ×104 pRBCs of DS and
left untreated; (D) Mice infected with a mixture of 8 ×103 pRBCs of P. chabaudi adami DK, and 2 ×103 pRBCs of P. chabaud adami DS.
Sera were collected at different time points for ELISA tests. Each data point is the mean ± SEM for an experiment performed in triplicate.
However, SEM is not shown when it is too small. ( ) Sera from infected mice with DK or DS strains and reacted with the lysate of pRBCs
of P. chabaudi adami DK or DS. ( ) Sera from DK-or DS-infected mice reacted with the lysate of RBCs of naïve mice. ( ) Sera from naïve
mice reacted with the lysate of pRBCs of DK or DS strains. ( ) Sera from naïve mice reacted to the lysate of RBCs from naïve control
mice.
response before the threshold for clinical disease is reached [38,
40]. We, however, observed no alteration in the profile of the
immune response in resistant NIH mice in either single or mixed
infections of DK or DS strains of P. chabaudi adami. 
We showed that recovery from the primary peak parasitemia
during a single P. chabaudi adami DK and DS or DK and DS
mixed infections in NIH mice is associated with a Th1 response,
with high levels of IFN-g [41] and high levels of specific IgG2a
antibody at or immediately after the peak parasitemia. The pre-
dominant Th1 cell-mediated response was followed by a Th2
response with high levels of IL-4 and specific IgG1 antibody,
particularly on the last sampling days which was coincident with
the chronic phase of the infection. This suggests that sequential
Th1/Th2 response are induced. Our findings are in agreement
with previous studies in which both Th1 and Th2 subsets [42,
43] are crucial for the resolution of the acute primary parasitemia
in the P. chabaudi adami model [44] and in a self-resolving infec-
tion of P. chabaudi AS [4,45]. 
In respect of IL-4 production, in the avirulent DK infection,
the IL-4 levels were significantly lower than those in the virulent
DS infections, an indicative of stronger Th2 response in DS-infect-
ed mice compared to DK-infected mice. In the mixed infection,
also higher levels of IL-4 were recorded on the first sampling
day compared to the single infections with DK or DS strains in
untreated mice. Therefore, it may be proposed that there was a
stronger Th1 response in the single infection while a Th2 response
was relatively stronger in the mixed infection. Our observation
of increased IL-4 and specific IgG1 antibody levels later in our
experiments was also in agreement with those who have sug-
gested that there is a switching from a Th1 to a Th2 response in
some murine malaria parasite infections [43,45]. This switching
could happen when IL-4 initiates to rise as an anti-inflammatory
cytokines, such as IFN-g [46]. 
We also observed that the co-presence of the avirulent DK
strain with the DS strain in the mixed infection moderates the
virulence of the virulent strain. In this regard, although the non-
immunological effects or exact interactions between DK and DS
strains regarding development of the immune response are not
clear, there are some possible explanations. A non-immunologi-
cal possibility could be competition between the 2 strains for
essential nutrients for growth, such as para-aminobenzoic acid. 
Some immunological possibilities could be as follows: First,
the presence of DK strain can activate, as described before, Th1
response dependent mechanisms such as specific IgG2a produc-
tion or non-specific macrophage activation, production of nitric
oxide or oxygen radicals. These mechanisms as they control the
DK infection may also have a bystander effect on DS parasites
and apparently to reduce the virulence of the DS strain and there-
by, the severity of disease might be ameliorated. Secondly, cross-
reactions could be another possibility as indicated by Cox and
Voller [27] between rodent malaria parasites. In the present
study, it may be supposed that when the immune system devel-
ops specific responses to the antigens of DK strain these respons-
es non-specifically have some effective cross-reactions against
the shared antigens in the DS strain parasites. Therefore, in the
mixed infection, a lower peak parasitemia and no deaths were
observed compared with the DS single infection. It is also possi-
ble that priming with DK antigens could promote specific re-
sponses to the DS strain. 
Our study showed much more rapid parasite load of the DS
strain and its greater virulence compared with the DK strain infec-
tion when a mixed infective dose was administered at a fixed
ratio. Therefore, further studies in which different ratios should
be used may provide better understanding of interactions between
the 2 strains. 
We observed that an early rise in IFN-g with a sharp decline
at the peak parasitemia was followed by another rise later dur-
ing the infection. Therefore, as some previous studies [2,47], we
assumed that stimulation of non-specific immunity may be a
source of the early rise in IFN-g measured on day 4. It, therefore,
appears that the immune response in P. chabaudi adami DS and
DK starts to balance inflammatory and anti-inflammatory cy-
tokines around the time of peak parasitemia because the rise in
IL-4 begins after the peak. Nevertheless, understanding which
mechanisms and effector cells are involved in the decrease of
IFN-g in splenocytes taken at the time of the peak parasitemia
merits more investigations. 
The Th1-Th2 cytokine balance influences the regulation of
IgG2a and IgG1 isotypes [48]. In lethal infections, there is a cor-
relation between fatal outcome and slower, reduced specific Ig-
G2a antibody [6]. However, our results showed that the levels
of IgG2a relatively increased again later during the course of the
DS infection in surviving mice besides elevation of specific IgG1
antibody.
We showed that IL-4 and igG1 increased later in the course of
infections in both avirulent and virulent infections as a marker
for switching from Th1 to Th2 response [5,45]. The same obser-
vation was indicated by Taylor-Robinson and Phillips [16] in
the infection with P. chabaudi chabaudi AS in NIH. Our results
are in agreement with von der Weid et al. [49] and van der Heyde
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et al. [50] who suggested that the presence of IL-4 is not essen-
tial for the primary control of parasitemia. IL-4 deficient mice
recovered from P. chabaudi and P. yoelii infections, whereas, in
IFN-g receptor deficient mice, the primary parasitemia failed to
decline to a sub-patent level with a high mortality rate and an
elevated Th2 response [15].
Our study suggests that there is a normal functioning immune
response in infected mice in which both arms of Th1 and Th2
provide flexibility and balance to control the parasites during
the course of infection. However, in the virulent infection, the
predominant Th1 response is not adequate to save all mice from
death. However, recent studies showed that in addition to Th1
and Th2 subsets, Th17 and T regulatory subsets and cytokines
such as IL-10 and TGF b‚ are also involved in the regulation of
the immune response to malaria [51] and other infections such
as toxoplasmosis [52] and schistosomisis [53]. These recent find-
ings show other different fields which merit to be investigated in
malaria parasites infections in order to understand true interac-
tions which form the final outcome of the immune responses
in either single or mixed malaria infections. 
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